Erratum for Safety and efficacy of a novel bioabsorbable, steroid-eluting sinus stent (International Forum of Allergy & Rhinology, (2011), 1, 1, (23-32), 10.1002/alr.20020);Safety and efficacy of a novel bioabsorbable, steroid-eluting sinus stent

International Forum of Allergy and Rhinology

Volumn 1, Issue 1, 2011, Pages 23-32

  Murr, Andrew H ^a   Smith, Timothy L ^b   Hwang, Peter H ^c   Bhattacharyya, Neil ^d   Lanier, Brent J ^e   Stambaugh, James W ^f   Mugglin, Andrew S ^g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e Central California ENT Medical Group   (United States)

^f Intersect ENT   (United States)

^g UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Bioabsorbable; Corticosteroid; FESS; Functional endoscopic sinus surgery; Inflammation; Sinusitis; Stent; Steroid eluting; Turbinate

Indexed keywords

STEROID; ANTIINFLAMMATORY AGENT; MOMETASONE FUROATE; PREGNANE DERIVATIVE;

ADULT; AGED; ARTICLE; BIODEGRADABLE IMPLANT; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ELUTING STENT; ENDOSCOPIC SINUS SURGERY; ENDOSCOPY; FEMALE; FOLLOW UP; HUMAN; MALE; MULTICENTER STUDY; PARANASAL SINUSITIS; POLYP; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOSINUSITIS; RISK ASSESSMENT; SAFETY; SCORING SYSTEM; SINUS STENT; TREATMENT OUTCOME; TURBINATE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; EQUIPMENT DESIGN; ETHMOID SINUS; METHODOLOGY; MIDDLE AGED; NOSE POLYP; ORAL DRUG ADMINISTRATION; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; RHINITIS; TISSUE ADHESION; WOUND HEALING;

ABSORBABLE IMPLANTS; ADMINISTRATION, ORAL; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; CHRONIC DISEASE; DOUBLE-BLIND METHOD; DRUG-ELUTING STENTS; ENDOSCOPY; EQUIPMENT DESIGN; ETHMOID SINUS; ETHMOID SINUSITIS; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL POLYPS; POSTOPERATIVE COMPLICATIONS; PREGNADIENEDIOLS; PROSPECTIVE STUDIES; RHINITIS; STEROIDS; TISSUE ADHESIONS; TREATMENT OUTCOME; TURBINATES; WOUND HEALING;

EID: 80055038293     PISSN: 20426976     EISSN: 20426984     Source Type: Journal    
DOI: 10.1002/alr.22387     Document Type: Erratum

References (40)

1. Kennedy DW, Zinreich SJ, Rosenbaum AE, Johns ME. Functional endoscopic sinus surgery. Theory and diagnostic evaluation. Arch Otolaryngol. 1985;111:576-582.
2. Otto KJ, DelGaudio JM. Operative findings in the frontal recess at time of revision surgery. Am J Otolaryngol. 2010;31:175-180.
3. Kennedy DW, Wright ED, Goldberg AN. Objective and subjective outcomes in surgery for chronic sinusitis. Laryngoscope. 2000;110(3 Pt 3):29-31.
4. Wormald PJ, Boustred RN, Le T, Hawke L, Sacks R. A prospective single-blind randomized controlled study of use of hyaluronic acid nasal packs in patients after endoscopic sinus surgery. Am J Rhinol. 2006;20:7-10.
5. Li PM, Downie D, Hwang PH. Controlled steroid delivery via bioabsorbable stent: safety and performance in a rabbit model. [Erratum: Am J Rhinol Allergy. 2010;24:165.] Am J Rhinol Allergy. 2009;23:591-596.
6. Salman SD. A new stent for endoscopic sinus surgery, Otolaryngol Head Neck Surg. 1993;109:780-781.
7. Côté DW, Wright ED. Triamcinolone-impregnated nasal dressing following endoscopic sinus surgery: a randomized, double-blind, placebo-controlled study. Laryngoscope. 2010;120:1269-1273.
8. Sherris DA, Ponikau JU, Kern EB. Eosinophilic mucin rhinosinusitis. Laryngoscope. 2001;111:1670-1672.
9. Murr AH, Goldberg AN, Vesper S. Fungal speciation using quantitative polymerase chain reaction (QPCR) in patients with and without chronic rhinosinusitis. Laryngoscope. 2006;116:1342-1348.
10. Ferguson BJ, Otto BA, Pant H. When surgery, antibiotics, and steroids fail to resolve chronic rhinosinusitis. Immunol Allergy Clin North Am. 2009;29:719-732.
11. Kingdom TT, Lee KC, FitzSimmons SC, Cropp GJ. Clinical characteristics and genotype analysis of patients with cystic fibrosis and nasal polyposis requiring surgery. Arch Otolaryngol Head Neck Surg. 1996;122:1209-1213.
12. Wallwork B, Coman W, Feron F, Mackay-Sim A, Cervin A. Clarithromycin and prednisolone inhibit cytokine production in chronic rhinosinusitis. Laryngoscope. 2002;112:1827-1830.
13. Dubin MG, Liu C, Lin SY, Senior BA. American Rhinologic Society member survey on "maximal medical therapy" for chronic rhinosinusitis. Am J Rhinol. 2007;21:483-488.
14. Desrosiers MY, Kilty SJ. Treatment alternatives for chronic rhinosinusitis persisting after ESS: what to do when antibiotics, steroids and surgery fail [Review]. Rhinology. 2008;46:3-14.
15. Van Zele T, Gevaert P, Holtappels G, et al. Oral steroids and doxycycline: two different approaches to treat nasal polyps. J Allergy Clin Immunol. 2010;125:1069.e4-1076.e4.
16. Mullol J, Obando A, Pujols L, Alobid I. Corticosteroid treatment in chronic rhinosinusitis: the possibilities and the limits [Review]. Immunol Allergy Clin North Am. 2009;29:657-668.
17. Thomas M, Yawn BP, Price D, et al. European Position Paper on Rhinosinusitis and Nasal Polyps Group. EPOS Primary Care Guidelines: European position paper on the primary care diagnosis and management of rhinosinusitis and nasal polyps 2007-a summary [Review]. Prim Care Respir J. 2008;17:79-89.
18. Landsberg R, Segev Y, DeRowe A, et al. Systemic corticosteroids for allergic fungal rhinosinusitis and chronic rhinosinusitis with nasal polyposis: a comparative study. Otolaryngol Head Neck Surg. 2007;136:252-257.
19. Red book: pharmacy's fundamental reference. Montvale, NJ Physicians' Desk Reference; 2009.
20. Joe SA, Thambi R, Huang J. A systematic review of the use of intranasal steroids in the treatment of chronic rhinosinusitis [Review]. Otolaryngol Head Neck Surg. 2008;139:340-347.
21. Tinkelman DG, Bronsky EA, Gross G, Schoenwetter WF, Spector SL. Efficacy and safety of budesonide inhalation powder (Pulmicort Turbuhaler) during 52 weeks of treatment in adults and children with persistent asthma. J Asthma. 2003;40:225-236.
22. Passàli D, Bernstein JM, Passali FM, et al. Treatment of recurrent chronic hyperplastic sinusitis with nasal polyposis. Arch Otolaryngol Head Neck Surg. 2003;129:656-659.
23. Welch KC, Thaler ER, Doghramji LL, Palmer JN, Chiu AG. The effects of serum and urinary cortisol levels of topical intranasal irrigations with budesonide added to saline in patients with recurrent polyposis after endoscopic sinus surgery. Am J Rhinol Allergy. 2010;24:26-28.
24. Bhattacharyya N, Fried MP. The accuracy of computed tomography in the diagnosis of chronic rhinosinusitis. Laryngoscope. 2003;113:125-129.
25. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis Initiative. Rhinosinusitis: developing guidance for clinical trials. J Allergy Clin Immunol. 2006;118(5 suppl):S17-S61.
26. Robinson JL, Griest S, James KE, Smith TL. Impact of aspirin intolerance on outcomes of sinus surgery. Laryngoscope. 2007;117:825-830.
27. Quinn JV, Wells GA. An assessment of clinical wound evaluation scales. Acad Emerg Med. 1998;5:583-586.
28. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation [Review]. Med Care. 2003;41:582-592.
29. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
30. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42:121-130.
31. Royal RM. Model robust confidence intervals using maximum likelihood estimators. Int Stat Rev. 1986;43, 221-226.
32. Onrust SV, Lamb HM. Mometasone furoate. A review of its intranasal use in allergic rhinitis [Review]. Drugs. 1998;56:725-745.
33. Wright ED, Agrawal S. Impact of perioperative systemic steroids on surgical outcomes in patients with chronic rhinosinusitis with polyposis: evaluation with the novel Perioperative Sinus Endoscopy (POSE) scoring system. Laryngoscope. 2007;117(11 Pt 2 Suppl 115):1-28.
34. Bhattacharyya N. Relationship between mucosal inflammation, computed tomography, and symptomatology in chronic rhinosinusitis without polyposis. Ann Otol Rhinol Laryngol. 2008;117:517-522.
35. Miller RS, Steward DL, Tami TA, et al. The clinical effects of hyaluronic acid ester nasal dressing (Merogel) on intranasal wound healing after functional endoscopic sinus surgery. Otolaryngol Head Neck Surg. 2003;128:862-869.
36. Hosemann W, Wigand ME, Göde U, Länger F, Dunker I. Normal wound healing of the paranasal sinuses: clinical and experimental investigations. Eur Arch Otorhinolaryngol. 1991;248:390-394.
37. Beule AG, Scharf C, Biebler KE, et al. Effects of topically applied dexamethasone on mucosal wound healing using a drug-releasing stent. Laryngoscope. 2008;118:2073-2077.
38. Beule AG, Steinmeier E, Kaftan H, et al. Effects of a dexamethasone-releasing stent on osteoneogenesis in a rabbit model. Am J Rhinol Allergy. 2009;23:433-436.
39. Bednarski KA, Kuhn FA. Stents and drug-eluting stents [Review]. Otolaryngol Clin North Am. 2009;42:857-866.
40. Lipworth BJ, Jackson CM. Safety of inhaled and intranasal corticosteroids: lessons for the new millennium [Review]. Drug Saf. 2000;23:11-33.